Skip to main content
Erschienen in: Journal of Neurology 6/2021

02.12.2019 | Review

Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window

verfasst von: Andrea Cerveró, Alfonso Casado, Javier Riancho

Erschienen in: Journal of Neurology | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Amyotrophic lateral sclerosis (ALS) is the most frequent degenerative disease affecting motor neurons (MN). ALS has been traditionally considered as a pure motor system disease; however, there are currently sufficient evidences supporting the involvement of other non-motor systems. Recently, the development and the implementation of the optical coherence tomography (OCT) have provided new data regarding the ocular involvement in the disease. In this sense, alterations in retinal nerve fiber layer thickness (RNFL), other retinal layers thicknesses such as outer nuclear layer (ONL) and inner nuclear layer (INL) and changes in the retinal blood vessels have been described in ALS patients. Interestingly, the study of ocular alterations in ALS appears not only as new biomarker tool, but also as a new opportunity to deep into the pathogenesis of the disease. In this article we will review and standardize published studies regarding OCT and ALS, emphasizing both their strengths and weaknesses.
Literatur
1.
Zurück zum Zitat Riancho J, Lozano-Cuesta P, Santurtun A, Sanchez-Juan P, Lopez-Vega JM, Berciano J et al (2016) Amyotrophic lateral sclerosis in northern Spain 40 years later: what has changed? Neurodegener Dis 16(5–6):337–341CrossRef Riancho J, Lozano-Cuesta P, Santurtun A, Sanchez-Juan P, Lopez-Vega JM, Berciano J et al (2016) Amyotrophic lateral sclerosis in northern Spain 40 years later: what has changed? Neurodegener Dis 16(5–6):337–341CrossRef
2.
Zurück zum Zitat Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R et al (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol 142:104–129CrossRef Zufiria M, Gil-Bea FJ, Fernandez-Torron R, Poza JJ, Munoz-Blanco JL, Rojas-Garcia R et al (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog Neurobiol 142:104–129CrossRef
3.
Zurück zum Zitat Riancho J, Bosque-Varela P, Perez-Pereda S, Povedano M, de Munain AL, Santurtun A (2018) The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol 62(8):1361–1374CrossRef Riancho J, Bosque-Varela P, Perez-Pereda S, Povedano M, de Munain AL, Santurtun A (2018) The increasing importance of environmental conditions in amyotrophic lateral sclerosis. Int J Biometeorol 62(8):1361–1374CrossRef
4.
Zurück zum Zitat Riancho J, Gil-Bea FJ, Santurtun A, Lopez DM (2019) Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach. Neural Regener Res 14(2):193–196CrossRef Riancho J, Gil-Bea FJ, Santurtun A, Lopez DM (2019) Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach. Neural Regener Res 14(2):193–196CrossRef
5.
Zurück zum Zitat Hoon M, Okawa H, Della SL, Wong RO (2014) Functional architecture of the retina: development and disease. Prog Retin Eye Res 42:44–84CrossRef Hoon M, Okawa H, Della SL, Wong RO (2014) Functional architecture of the retina: development and disease. Prog Retin Eye Res 42:44–84CrossRef
6.
Zurück zum Zitat Liu Z, Wang H, Fan D, Wang W (2018) Comparison of optical coherence tomography findings and visual field changes in patients with primary open-angle glaucoma and amyotrophic lateral sclerosis. J Clin Neurosci 48:233–237CrossRef Liu Z, Wang H, Fan D, Wang W (2018) Comparison of optical coherence tomography findings and visual field changes in patients with primary open-angle glaucoma and amyotrophic lateral sclerosis. J Clin Neurosci 48:233–237CrossRef
7.
Zurück zum Zitat Ringelstein M, Albrecht P, Sudmeyer M, Harmel J, Muller AK, Keser N et al (2014) Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 1(4):290–297CrossRef Ringelstein M, Albrecht P, Sudmeyer M, Harmel J, Muller AK, Keser N et al (2014) Subtle retinal pathology in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 1(4):290–297CrossRef
8.
Zurück zum Zitat Hubers A, Muller HP, Dreyhaupt J, Bohm K, Lauda F, Tumani H et al (2016) Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J Neural Transm (Vienna ) 123(3):281–287CrossRef Hubers A, Muller HP, Dreyhaupt J, Bohm K, Lauda F, Tumani H et al (2016) Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging. J Neural Transm (Vienna ) 123(3):281–287CrossRef
9.
Zurück zum Zitat Simonett JM, Huang R, Siddique N, Farsiu S, Siddique T, Volpe NJ et al (2016) Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep 6:29187CrossRef Simonett JM, Huang R, Siddique N, Farsiu S, Siddique T, Volpe NJ et al (2016) Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci Rep 6:29187CrossRef
10.
Zurück zum Zitat Mukherjee N, McBurney-Lin S, Kuo A, Bedlack R, Tseng H (2017) Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS ONE 12(9):e0185242CrossRef Mukherjee N, McBurney-Lin S, Kuo A, Bedlack R, Tseng H (2017) Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS ONE 12(9):e0185242CrossRef
11.
Zurück zum Zitat Rohani M, Meysamie A, Zamani B, Sowlat MM, Akhoundi FH (2018) Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression. J Neurol 265(7):1557–1562CrossRef Rohani M, Meysamie A, Zamani B, Sowlat MM, Akhoundi FH (2018) Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: a window to disease progression. J Neurol 265(7):1557–1562CrossRef
12.
Zurück zum Zitat Abdelhak A, Hubers A, Bohm K, Ludolph AC, Kassubek J, Pinkhardt EH (2018) In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J Neurol 265(4):949–953CrossRef Abdelhak A, Hubers A, Bohm K, Ludolph AC, Kassubek J, Pinkhardt EH (2018) In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J Neurol 265(4):949–953CrossRef
13.
Zurück zum Zitat Roth NM, Saidha S, Zimmermann H, Brandt AU, Oberwahrenbrock T, Maragakis NJ et al (2013) Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol 20(8):1170–1176CrossRef Roth NM, Saidha S, Zimmermann H, Brandt AU, Oberwahrenbrock T, Maragakis NJ et al (2013) Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur J Neurol 20(8):1170–1176CrossRef
14.
Zurück zum Zitat Maresca A, la Morgia C, Caporali L, Valentino ML, Carelli V (2013) The optic nerve: a "mito-window" on mitochondrial neurodegeneration. Mol Cell Neurosci 55:62–76CrossRef Maresca A, la Morgia C, Caporali L, Valentino ML, Carelli V (2013) The optic nerve: a "mito-window" on mitochondrial neurodegeneration. Mol Cell Neurosci 55:62–76CrossRef
15.
Zurück zum Zitat Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436–1441CrossRef Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS et al (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436–1441CrossRef
16.
Zurück zum Zitat Toth RP, Atkin JD (2018) Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front Immunol 9:1017CrossRef Toth RP, Atkin JD (2018) Dysfunction of optineurin in amyotrophic lateral sclerosis and glaucoma. Front Immunol 9:1017CrossRef
17.
Zurück zum Zitat Riancho J, Gonzalo I, Ruiz-Soto M, Berciano J (2019) Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis. Neurologia 34(1):27–37CrossRef Riancho J, Gonzalo I, Ruiz-Soto M, Berciano J (2019) Why do motor neurons degenerate? Actualization in the pathogenesis of amyotrophic lateral sclerosis. Neurologia 34(1):27–37CrossRef
18.
Zurück zum Zitat Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P et al (2007) Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry 78(7):754–756CrossRef Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P et al (2007) Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry 78(7):754–756CrossRef
19.
Zurück zum Zitat Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical coherence tomography in Alzheimer's disease and other neurodegenerative diseases. Front Neurol 8:701CrossRef Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical coherence tomography in Alzheimer's disease and other neurodegenerative diseases. Front Neurol 8:701CrossRef
20.
Zurück zum Zitat Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40–49CrossRef Chrysou A, Jansonius NM, van Laar T (2019) Retinal layers in Parkinson's disease: a meta-analysis of spectral-domain optical coherence tomography studies. Parkinsonism Relat Disord 64:40–49CrossRef
21.
Zurück zum Zitat Manogaran P, Hanson JV, Olbert ED, Egger C, Wicki C, Gerth-Kahlert C et al (2016) Optical coherence tomography and magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder. Int J Mol Sci 17(11):1894CrossRef Manogaran P, Hanson JV, Olbert ED, Egger C, Wicki C, Gerth-Kahlert C et al (2016) Optical coherence tomography and magnetic resonance imaging in multiple sclerosis and neuromyelitis optica spectrum disorder. Int J Mol Sci 17(11):1894CrossRef
22.
Zurück zum Zitat Eraslan M, Balci SY, Cerman E, Temel A, Suer D, Elmaci NT (2016) Comparison of optical coherence tomography findings in patients with primary open-angle glaucoma and Parkinson disease. J Glaucoma 25(7):e639–e646CrossRef Eraslan M, Balci SY, Cerman E, Temel A, Suer D, Elmaci NT (2016) Comparison of optical coherence tomography findings in patients with primary open-angle glaucoma and Parkinson disease. J Glaucoma 25(7):e639–e646CrossRef
23.
Zurück zum Zitat Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M et al (2012) Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 314(1–2):97–101CrossRef Moss HE, McCluskey L, Elman L, Hoskins K, Talman L, Grossman M et al (2012) Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J Neurol Sci 314(1–2):97–101CrossRef
24.
Zurück zum Zitat Casado A, Cervero A, Lopez-de-Eguileta A, Fernandez R, Fonseca S, Gonzalez JC et al (2019) Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects. PLoS ONE 14(9):e0222347CrossRef Casado A, Cervero A, Lopez-de-Eguileta A, Fernandez R, Fonseca S, Gonzalez JC et al (2019) Topographic correlation and asymmetry analysis of ganglion cell layer thinning and the retinal nerve fiber layer with localized visual field defects. PLoS ONE 14(9):e0222347CrossRef
25.
Zurück zum Zitat Lopez-de-Eguileta A, Lage C, Lopez-Garcia S, Pozueta A, Garcia-Martinez M, Kazimierczak M et al (2019) Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET. Alzheimers Dement (NY) 5:570–578CrossRef Lopez-de-Eguileta A, Lage C, Lopez-Garcia S, Pozueta A, Garcia-Martinez M, Kazimierczak M et al (2019) Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET. Alzheimers Dement (NY) 5:570–578CrossRef
26.
Zurück zum Zitat Cabrera DD, Somfai GM, Koller A (2017) Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol 312(2):H201–H212CrossRef Cabrera DD, Somfai GM, Koller A (2017) Retinal microvascular network alterations: potential biomarkers of cerebrovascular and neural diseases. Am J Physiol Heart Circ Physiol 312(2):H201–H212CrossRef
27.
Zurück zum Zitat Liew G, Wang JJ, Mitchell P, Wong TY (2008) Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging 1(2):156–161CrossRef Liew G, Wang JJ, Mitchell P, Wong TY (2008) Retinal vascular imaging: a new tool in microvascular disease research. Circ Cardiovasc Imaging 1(2):156–161CrossRef
28.
Zurück zum Zitat Buckley AF, Bossen EH (2013) Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J Neuropathol Exp Neurol 72(10):906–918CrossRef Buckley AF, Bossen EH (2013) Skeletal muscle microvasculature in the diagnosis of neuromuscular disease. J Neuropathol Exp Neurol 72(10):906–918CrossRef
29.
Zurück zum Zitat Kolde G, Bachus R, Ludolph AC (1996) Skin involvement in amyotrophic lateral sclerosis. Lancet 347(9010):1226–1227CrossRef Kolde G, Bachus R, Ludolph AC (1996) Skin involvement in amyotrophic lateral sclerosis. Lancet 347(9010):1226–1227CrossRef
30.
Zurück zum Zitat Bulut M, Kurtulus F, Gozkaya O, Erol MK, Cengiz A, Akidan M et al (2018) Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia. Br J Ophthalmol 102(2):233–237CrossRef Bulut M, Kurtulus F, Gozkaya O, Erol MK, Cengiz A, Akidan M et al (2018) Evaluation of optical coherence tomography angiographic findings in Alzheimer's type dementia. Br J Ophthalmol 102(2):233–237CrossRef
Metadaten
Titel
Retinal changes in amyotrophic lateral sclerosis: looking at the disease through a new window
verfasst von
Andrea Cerveró
Alfonso Casado
Javier Riancho
Publikationsdatum
02.12.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 6/2021
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09654-w

Weitere Artikel der Ausgabe 6/2021

Journal of Neurology 6/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.